Zymergen Inc. (ZY): Price and Financial Metrics Recent IPO

Zymergen Inc. (ZY): $44.43

0.76 (+1.74%)

POWR Rating

Component Grades













Add ZY to Watchlist
Sign Up

Industry: Chemicals


of 99

in industry

ZY Stock Price Chart Interactive Chart >

Price chart for ZY

ZY Price/Volume Stats

Current price $44.43 52-week high $52.00
Prev. close $43.67 52-week low $25.75
Day low $43.23 Volume 1,094,900
Day high $45.30 Avg. volume 456,997
50-day MA $0.00 Dividend yield N/A
200-day MA $0.00 Market Cap 4.46B

Zymergen Inc. (ZY) Company Bio

Zymergen Inc. designs, engineers, and optimizes microbes for industrial applications in United States, Asia, and Europe. The company has a platform that treats the genome as a search space, to identify genetic changes that improve the economics for its customers' bio-based products for a range of industries, including chemicals and materials, agriculture, and pharmaceuticals. Zymergen's platform is used to discover novel molecules used to enable unique material properties. The company was incorporated in 2013 and is based in Emeryville, California.

ZY Latest News Stream

Event/Time News Detail
Loading, please wait...

ZY Latest Social Stream

Loading social stream, please wait...

View Full ZY Social Stream

Latest ZY News From Around the Web

Below are the latest news stories about Zymergen Inc that investors may wish to consider to help them evaluate ZY as an investment opportunity.

Zymergen to Present at Goldman Sachs Annual Global Healthcare Conference

EMERYVILLE, Calif., June 07, 2021 (GLOBE NEWSWIRE) -- Biofacturing leader Zymergen today announced the company will be participating in the upcoming Goldman Sachs Annual Global Healthcare Virtual Conference. Zymergen’s management is scheduled to present on Wednesday, June 9th at 5:30 p.m. Eastern Time/2:30 p.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.zymergen.com/. About

Yahoo | June 7, 2021

7 Best Tech Stocks Pumped Out by Softbank’s ‘Golden Egg’ Machine

Tech stocks are on display in Softbank's Vision Fund.

Alex Sirois on InvestorPlace | May 26, 2021

Zymergen, Inc. (ZY) CEO Josh Hoffman on Q1 2021 Results - Earnings Call Transcript

Zymergen, Inc. (ZY) Q1 2021 Earnings Conference Call May 24, 2021, 16:30 PM ET Company Participants Niraj Javeri - IR Josh Hoffman - Co-Founder and Chief Executive Officer Enakshi Singh - Chief Financial Officer. Conference Call Participants Doug Schenkel - Cowen Tycho Peterson - JP Morgan Matt Sykes - Goldman...

SA Transcripts on Seeking Alpha | May 25, 2021

Zymergen EPS misses by $5.26, beats on revenue

Zymergen (ZY): Q1 GAAP EPS of -$6.51 misses by $5.26.Revenue of $3.74M (+26.8% Y/Y) beats by $0.82M.Press Release...

Seeking Alpha | May 24, 2021

Zymergen to Report First Quarter 2021 Financial Results on May 24, 2021

EMERYVILLE, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Biofacturing leader Zymergen, today announced it will report financial results for the first quarter 2021 after market close on Monday, May 24th, 2021. The company’s management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. A webcast of the conference call can be accessed at https://investors.zymergen.com/. The webcast will be archived and available for replay for at least 90 days after the event. About Zymergen Zymergen is a biofacturing company using biology to reimagine the world. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value to customers in a broad range of indus...

Yahoo | May 13, 2021

Read More 'ZY' Stories Here

ZY Price Returns

1-mo 22.87%
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7319 seconds.